Sign In
Buy BAX
$18.54
-0.140 (-0.749%)
At Close: Jun 03, 2026
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
11:55am, Wednesday, 30'th Apr 2025
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Baxter to Present at Bank of America Securities 2025 Health Care Conference
04:15pm, Tuesday, 29'th Apr 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Jo
Will BAX's Q1 Earnings Improve Following Transformation Completion?
02:20pm, Monday, 28'th Apr 2025
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
09:16am, Thursday, 10'th Apr 2025
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
09:15am, Thursday, 10'th Apr 2025
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st
Baxter to Host Annual Meeting of Stockholders in Virtual Format
09:00am, Wednesday, 26'th Mar 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday,
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq
10:15am, Thursday, 06'th Mar 2025
At the 2025 HIMSS Global Healthcare Conference, BAX unveils its Voalte Linq device, powered by Scotty assistant, a voice-activated technology.
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
09:00am, Tuesday, 04'th Mar 2025
LAS VEGAS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Medical Penlight Market Size, Share & Trends Analysis Report By Type (Consumables, Equipment), By Light Output (Oncology, Cardiovascular Diseases), By U
Kontoor Brands CEO Scott Baxter sits down with Jim Cramer
08:21pm, Thursday, 20'th Feb 2025
Kontoor Brands Chair, President, and CEO Scott Baxter joins 'Mad Money' host Jim Cramer to talk acquiring Helly Hansen, international business, and more.
BAX Stock Surges Following Q4 Earnings & Sales Beat, Margins Decline
02:35pm, Thursday, 20'th Feb 2025
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract.
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
12:42pm, Thursday, 20'th Feb 2025
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
12:41pm, Thursday, 20'th Feb 2025
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say
11:30am, Thursday, 20'th Feb 2025
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise
08:17am, Thursday, 20'th Feb 2025
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.
